Blog
We’re starting the year with momentum at USDTL. Planning is underway on a new state-of-the-art laboratory facility in Chicago; an investment in our growth, innovation, and ability to serve our partners well into the future.
At the same time, we’re excited to share that USDTL is now processing clinical specimens alongside our long-standing forensic testing. Backed by decades of toxicology expertise, this marks an important step toward expanding how we support the testing community.
- USDTL’s Integration and Partnership With CourtFact
- New Year, New Capabilities: Offering Forensic & Clinical Testing Options
- Weather Delay
- The Detection of Delta-9-tetrahydrocannabinol, Delta-8-tetrahydrocannabinol, Delta-10-tetrahydrocannabinol, and Cannabidiol in Hair Specimens
- Umbilical Cord Tissue Testing for Ketamine
- Drugs of Abuse: A DEA Resource Guide (2024)
- Beyond THC and CBD: Understanding New Cannabinoids
- New Xylazine, Psilocin, Gabapentin, Dextromethorphan, and Extended Cannabinoids Testing at USDTL
- January 2026 (3)
- October 2025 (1)
- July 2025 (3)
- May 2025 (2)
- April 2025 (2)
- March 2025 (2)

